Multiple viral infections in a group of intravenous drug users: hepatitis B virus exposure is the risk factor

Citation
M. Santolamazza et al., Multiple viral infections in a group of intravenous drug users: hepatitis B virus exposure is the risk factor, EUR J GASTR, 13(11), 2001, pp. 1347-1354
Citations number
27
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
ISSN journal
0954691X → ACNP
Volume
13
Issue
11
Year of publication
2001
Pages
1347 - 1354
Database
ISI
SICI code
0954-691X(200111)13:11<1347:MVIIAG>2.0.ZU;2-0
Abstract
Objective Infection with hepatotropic viruses is associated with a variable degree of liver disease, and there is evidence that more severe lesions ar e related to the association with another viral infection. The aim of this investigation is to establish the relationship between different viral infe ctions occurring in the same individual and the presence and progression of liver disease. Design The study population comprises 754 intravenous (IV) drug abusers exp osed to hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodefic iency virus (HIV) or cytomegalovirus (CMV). All individuals were followed f or an average of 2 years. Liver disease was assessed by liver function test s, 99m-technetium (Tc-99m) liver scintigraphy, and also by liver biopsy in a subset (n = 136) of patients. The different viral patterns and presence o f disease were analysed by logistic regression, and the risk factors were c alculated. Contingency tables of patients with single or associated infecti ons were drawn up to evaluate progression of liver disease. Results Association of HIV with at least one other viral infection was cons tant. Surface antigens of HBV (HBsAg) were always associated with HIV (n = 19); in this group, 18 patients had signs of liver disease. A past infectio n with HBV, as revealed by the presence of at least antibodies against the surface antigen (HBsAb) and antibodies against the core antigen of HBV (HBc Ab), was detected in 463 patients (61.4%). The overall prevalence of HCV an tibodies was 63.91% (n = 482). In 96.8% of the 406 patients tested, HCV-RNA was detected by reverse transcriptase polymerase chain reaction (RT-PCR). The majority of patients with high alanine transaminase (ALT) had anti-HBV antibodies in the presence of HCV (56.1%). At the end of follow-up, all of these patients showed signs of active liver disease, and scoring was signif icantly worse than in patients with either HBV or HCV alone. An infection/r eactivation of CMV was found in patients previously exposed to HBV and with increased ALT values. Conclusions Data emerging from this study reveal the association of HCV or CMV, or both, with a previous HBV infection, as demonstrated by HBsAb and H BcAb, and rapid progression of the disease in this group of patients. A pre vious HBV infection therefore appears to be an important risk factor for su bsequent viral-related liver disease. (C) 2001 Lippincott Williams & Wilkin s.